$327 million civil penalty against Johnson & Johnson upheld by South Carolina judge
In March of this year, a jury found Johnson & Johnson guilty of overstating the safety of its former bestseller antipsychotic, Risperdal. Now, a South Carolina judge has ruled that the $327 million civil penalty against the company should stand.
Risperdal was once bringing in billions of dollars in sales for J&J, but the company has faced lawsuits over improper marketing and marketing for off-label uses.
Consumer lawsuits over Risperdal side effects and off-label uses
Several states (including California, Florida, Illinois, and Texas) have filed against Janssen Pharmaceuticals (a Johnson & Johnson subsidiary) for claims that the company failed to disclose serious risks including:
- excessive weight gain,
- increased stroke risk,
- increased risk of death (for elderly dementia patients),
- Neuroleptic Malignant Syndrome (NMS), and
- Tardive Dyskinesia.
Doctors prescribed the drug for many uses including Alzheimer’s, aggression and anxiety in elderly patients, but also for children with autism or behavioral disorders.
States have made allegations that the companies make misleading statements to doctors about the drug’s safety and paying doctors to prescribe the drug when they otherwise would not.
Have you or a loved one suffered after taking Risperdal?
If you have suffered the consequences of taking Risperdal you should contact a board certified lawyer immediately to investigate your case. Many consumers have filed lawsuits against the company for dangerous Risperdal side effects.
Contact our board certified personal injury attorneys today to discuss your case for free. We work on a contingency fee basis, which means if we don’t make a recovery in your case you do not owe us anything.
FAQ: Do I have a Risperdal lawsuit?